DOI QR코드

DOI QR Code

Protective Effect of Litsea japonica Fruit Flesh Extract on Stress-induced Gastritis in Rats

흰쥐에서 스트레스로 유발된 위염에 대한 까마귀쪽나무열매 추출물의 보호 효과

  • Received : 2017.09.25
  • Accepted : 2017.10.10
  • Published : 2017.12.30

Abstract

The object of this study was to investigate the inhibitory effects of Litsea japonica fruit flesh extract (LJF-HE) on gastritis of an stress-induced SD rat model. Rats were randomly divided into six groups: Normal (normal group), Control (stress-induced gastritis), Ranitidine (stress-induced gastritis and ranitidine 50 mg/kg), LJF-HE-L (stress-induced gastritis pretreated with L. japonica fruit flesh extract at 30 mg/kg), LJF-HE-M (stress-induced gastritis pretreated with L. japonica fruit flesh extract at 60 mg/kg), LJF-HE-H (stress-induced gastritis pretreated with L. japonica fruit flesh extract at 120 mg/kg). In groups treated with LJF-HE, gastric mucosal damage and pepsin activity were reduced. Additionally, there were decreases in the expression of cholecystokinin 2 receptor (CCK-2r) in the gastric lesions. The plasma levels of IL-$1{\beta}$ slightly but significantly decreased in LJF-HE treated groups compared to control. The plasma level of PGE2 was also significantly increased in LJF-HE treated groups. These results suggest that LJF-HE has the ability to reduce of the severity stress-induced gastritis.

본 연구는 까마귀쪽나무열매추출물(LJF-HE)이 흰쥐모델에서 스트레스로 유발되어지는 위염에 대한 억제효과를 확인하고자 하였다. 이때 까마귀쪽나무열매추출물(LJF-HE)소재는 지표성분인 hamabiwalactone B의 함량이 $15.23{\pm}0.057mg/g$로 규격에 적합한 것을 사용하였다, 동물실험에 있어 군분리는 정상군(normal), 양성 대조군(control, 수침 구속 스트레스 위염 유발), 약물 대조군(ranitidine, 50 mg/kg), 까마귀쪽나무열매추출물 저농도 투여군(LJF-HE-L, 30 mg/kg), 까마귀쪽나무열매추출물 중농도 투여군(LJF-HE-M, 60 mg/kg), 까마귀쪽나무열매추출물 고농도 투여군(LJF-HE-H, 120 mg/kg)의 총 6군으로 구성하여 실험을 진행하였다. 그 결과 까마귀쪽나무열매추출물의 투여그룹(LJF-HE-L, LJF-HE-M, LJF-HE-H)에서 염증의 길이가 control 그룹에 비하여 통계적으로 유의하게 감소하였으며, 육안 병변 관찰에서도 까마귀쪽나무열매추출물(LJF-HE) 투여그룹에서의 위 염증과 점막출혈 부위가 control 그룹에 비하여 감소하였음을 관찰할 수 있었다. 또한 까마귀쪽나무열매추출물(LJF-HE) 투여그룹에서의 펩신 활성도도 control 대비 유의성 있게 감소하는 것으로 나타나 까마귀쪽나무 열매추출물은 펩신 활성도를 낮춰 위염 발생을 억제하는 것으로 사료된다. 그리고 까마귀쪽나무열매추출물의 투여 그룹(LJF-HE-M, LJF-HE-H)에서 gastrin에 의해 활성화 되는 CCK-2r 유전자 발현이 대조군에 비해 유의적으로 억제되는 것으로 나타났으며, 염증성 cytokine중에 하나인 IL-$1{\beta}$의 혈장 내 함량이 대조군에 비해 유의적으로 감소하였고, 세포보호물질로 점액 및 혈류량을 증가시켜 위점막을 보호하는 역할을 하는 PGE2의 혈장 내 함량이 대조군에 비해 유의적으로 증가한 결과를 얻었다. 이와 같은 결과는 까마귀쪽나무열매추출물(LJF-HE)이 스트레스로 유발되어지는 위염에 대한 억제효과가 있음을 확인하였다.

Keywords

References

  1. Glickman JN, Antonioli DA: Gastritis. Gastrointest Endosc Clin North Am, 11, 717-740 (2001). https://doi.org/10.1016/S1052-5157(18)30044-8
  2. Kandulski A, Selgrad M, Malfertheiner P: Helicobacter pylori infection: a clinical overview. Dig. Liver Dis., 40, 619-626 (2008). https://doi.org/10.1016/j.dld.2008.02.026
  3. Srivastava A, Lauwers GY: Pathology of non-infective gastritis. Histopathology, 50, 15-29 (2007). https://doi.org/10.1111/j.1365-2559.2006.02553.x
  4. Franke A, Teyssen S, Singer MV: Alcohol-related diseases of the esophagus and stomach. Dig Dis, 23, 204-213 (2005). https://doi.org/10.1159/000090167
  5. Liu ES, Cho CH: Relationship between ethanol-induced gastritis and gastric ulcer formation in rats. Digestion, 62, 232- 239 (2000). https://doi.org/10.1159/000007821
  6. Chew CS: Intracellular mechanisms in control of acid secretion. Curr. Opin. Gastroenterol., 7, 856-862 (1991). https://doi.org/10.1097/00001574-199112000-00004
  7. Mardh S, Song YH, Carlsson C, Bjrkman T: Mechanisms of stimulation of acid production in parietal cells isolated from the pig gastric mucosa. Acta Physiol. Scand., 131, 589-598 (1987). https://doi.org/10.1111/j.1748-1716.1987.tb08280.x
  8. Helander HF, Keeling DJ: Cell biology of gastric acid secretion. Baillieres Clin Gastroenterol, 7, 1-21 (1993). https://doi.org/10.1016/0950-3528(93)90029-R
  9. Berardi RR, Savitsky ME, Nostrant TT: Maintenance therapy for prevention of recurrent peptic ulcers. Drug Intell. Clin. Pharm., 21, 493-501 (1987). https://doi.org/10.1177/106002808702100602
  10. Fullarton GM, McLauchlan G, Macdonald A, Crean GP, McColl KE: Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut, 30, 449-54 (1989). https://doi.org/10.1136/gut.30.4.449
  11. Szabo S, Bynum TE: Alternatives to the acid-oriented approach to ulcer disease: does 'cytoprotection' exist in man? A new classification of antiulcer agents. Scand. J. Gastroenterol., 23, 1-6 (1988).
  12. Min BS, Lee SY, Kim JH, Kwon OK, Park BY, An RB, Lee JK, Moon HI, Kim TJ, Kim YH, Joung H, Lee HK: Lactones from the leaves of the Litsea japonica and their anti-complement activity. J. Nat. Prod., 66,1388-1390 (2003). https://doi.org/10.1021/np030227i
  13. Jimenez-Perez N del C, Lorea-Hernandez FG, Jankowski CK, Reyes-Chilpa R: Essential oils in mexican bays (Litsea spp., Lauraceae): Taxonomic assortment and ethnobotanical implications. Econ Bot., 65,178-189 (2011). https://doi.org/10.1007/s12231-011-9160-5
  14. Okebe S, Jino H, Nishida A: Effects of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on gastric secretion and various gastric lesions induced in rats. Jpn. J. Pharmacol., 40, 329-337 (1986). https://doi.org/10.1254/jjp.40.329
  15. Sciffers MJ, Segal HL, Miller LL: Separation of pepsinogen I, pepsinogen II, and pepsinogen III from human gastric mucosa. Am. J. Physiol., 205, 1106-1111 (1963).
  16. Chen D, Zhao CM: Complexity of gastric acid secretion revealed by targeted gene disruption in mice. Curr. Pharm. Des., 16, 1235-1240 (2010). https://doi.org/10.2174/138161210790945904
  17. Schubert ML: Gastric secretion. Curr. Opin. Gastroenterol., 23, 595-601 (2007). https://doi.org/10.1097/MOG.0b013e3282f03462
  18. Osawa H, Kita H, Ohnishi H, Hoshino H, Mutoh H, Ishino Y, Watanabe E, Satoh K, Sugano K: Helicobacter pylori eradication induces marked increase in $H^+/K^+$ adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa. Gut, 55, 152-157 (2006). https://doi.org/10.1136/gut.2005.066464